Can the 2-(13)C-uracil breath test be used to predict the effect of the antitumor drug S-1?

Cancer Chemotherapy and Pharmacology
Yukimoto IshiiSatoshi Asai

Abstract

S-1 is an oral anticancer drug containing tegafur (FT), a pro-drug of fluorouracil, combined with two modulators, 5-chloro-2,4-dihydroxypyridine and potassium oxonate (Oxo), at a molar ratio of 1:0.4:1. CYP2A6 genetic polymorphism and dihydropyrimidine dehydrogenase (DPD) inhibition are important for the antitumor effect of S-1. Exploiting the usefulness of the 2-(13)C-uracil breath test (UrBT) as an indicator of DPD activity, we examined whether the results of CYP2A6 genetic polymorphism analysis and UrBT could be used to predict the antitumor effect of S-1. Thirty-four patients with advanced or recurrent cancer (15, 16 and 3 with gastric, colorectal and pancreatic cancer, respectively) were orally administered 40 mg/m(2) S-1 twice daily in the morning and evening. Eighteen patients with a complete response (CR)/partial response (PR) (2 with CR, 16 with PR) and 16 with progressive disease (PD) were compared with respect to CYP2A6 genetic polymorphisms (1- vs. 2-allele mutation), UrBT results, and plasma FT and 5-fluorouracil levels at 3 h after S-1 ingestion in the morning. On multivariate analysis between the CR/PR and PD groups, only the UrBT results was an independent factor of CR/PR to S-1 (95% CI 1.02-1.10). These results...Continue Reading

References

Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y SakataT Taguchi
Mar 10, 2001·Biochemical and Biophysical Research Communications·N AriyoshiT Kamataki
Jun 8, 2001·Biochemical and Biophysical Research Communications·M PitarqueM Ingelman-Sundberg
Jan 10, 2002·Biochemical and Biophysical Research Communications·C XuR F Tyndale
Mar 27, 2002·The Pharmacogenomics Journal·S T PullarkatH J Lenz
May 23, 2002·International Journal of Colorectal Disease·David J ParkHeinz-Josef Lenz
Apr 20, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·André B P van Kuilenburg
Apr 23, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lori K MattisonRobert B Diasio
Jul 1, 2004·FEBS Letters·Miki NakajimaTsuyoshi Yokoi
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Jiro KajitaHiroyuki Kobayashi
Apr 9, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elizabeth A KiddHoward L McLeod
Feb 4, 2006·Current Drug Metabolism·Ken-ichi Fujita
Jul 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wataru IchikawaRenzo Hirayama
Sep 6, 2006·Clinical Pharmacology and Therapeutics·Miki NakajimaTsuyoshi Yokoi
Oct 27, 2006·Nucleosides, Nucleotides & Nucleic Acids·M InadaH Sato

❮ Previous
Next ❯

Citations

Nov 10, 2009·Pharmacogenetics and Genomics·Caroline F ThornRuss B Altman
Oct 14, 2011·Future Oncology·Richard J E SkipworthJames A Ross
Jul 23, 2013·Clinical Pharmacokinetics·Frans L OpdamHenk-Jan Guchelaar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Barbara BradenWolfgang F Caspary
Best Practice & Research. Clinical Gastroenterology
Barbara Braden
© 2022 Meta ULC. All rights reserved